Hemolysis Testing

As identified in ISO 10993-4, elevated levels of free plasma hemoglobin may cause stress and toxicity for organ systems. Hemolysis, induced through physical damage of erythrocytes or through toxic extractables from a device, is evaluated using the procedure outlined in ASTM F756.

iuvo performs both static and mechanical hemolysis assessments as part of a GLP Biocompatibility package or as a screening tool during product development.

Contact Us Today

If you’re seeking comprehensive medical device services, look no further than iuvo Bioscience. Our experienced team is ready to assist you with testing, evaluation, and regulatory support to ensure successful commercialization of your medical device. Contact us today to discuss your project and learn how our expertise can help you get to market fast.